- Home
- USNA vs AUTL Comparison
USNA vs AUTL Comparison
Compare USNA & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | USNA | AUTL |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.5M | 433.8M |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | USNA | AUTL |
|---|---|---|
| Price | $19.51 | $1.89 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $36.00 | $8.67 |
| AVG Volume (30 Days) | 137.8K | ★ 2.6M |
| Earning Date | 02-24-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $912,670,000.00 | $51,128,000.00 |
| Revenue This Year | $9.80 | $669.49 |
| Revenue Next Year | N/A | $91.53 |
| P/E Ratio | $21.63 | ★ N/A |
| Revenue Growth | 5.88 | ★ 406.67 |
| 52 Week Low | $18.48 | $1.11 |
| 52 Week High | $38.32 | $2.80 |
Technical Indicators
Market Signals| Indicator | USNA | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 42.24 | 65.42 |
| Support Level | $19.44 | $1.63 |
| Resistance Level | $19.98 | $2.05 |
| Average True Range (ATR) | 0.49 | 0.11 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 11.38 | 68.31 |
Price Performance
Historical ComparisonAbout USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.